City

Bethesda (1)

Copenhagen (1)

Oslo (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Christian von Buchwald (1)

National Cancer Institute (NCI) (1)

Oslo University Hospital (1)

Collaborator

Copenhagen University Hospital, Denmark (1)

Department of Otorhinolaryngology, Head and Neck Surgery and Audiology (1)

Oslo Metropolitan University (1)

Intervention

intraoral stent (1)

liquid biopsy (1)

no intraoral stent (1)

pembrolizumab (1)

valemetostat (1)

Study Documents

Intervention Type

device (1)

diagnostic test (1)

drug (1)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

sinonasal cancer

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting

Sinonasal Cancer
+5 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jun 5, 2023

Oral Cavity Cancer, Sinonasal Cancer Trial in Oslo (Intraoral stent, No intraoral stent)

Recruiting

Oral Cavity Cancer
Sinonasal Cancer

Intraoral stent
No intraoral stent

Oslo, Norway

Oslo University Hospital

Aug 25, 2022

Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)

Recruiting

Head and Neck Cancer
+26 more

Liquid biopsy

Copenhagen, Region Hovedstaden, Denmark

University Hospital of Copenhagen, Rigshospitalet

Sep 14, 2021